Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells Journal Article


Authors: Subbaramaiah, K.; Chung, W. J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J. M.; Dannenberg, A. J.
Article Title: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
Abstract: We determined whether resveratrol, a phenolic antioxidant found in grapes and other food products, inhibited phorbol ester (PMA)-mediated induction of COX-2 in human mammary and oral epithelial cells. Treatment of cells with PMA induces COX-2 and causes a marked increase in the production of prostaglandin E2. These effects were inhibited by resveratrol. Resveratrol suppressed PMA-mediated increases in COX-2 mRNA and protein. Nuclear run-offs revealed increased rates of COX-2 transcription after treatment with PMA, an effect that was inhibited by resveratrol. PMA caused about a 6-fold increase in COX-2 promoter activity, which was suppressed by resveratrol. Transient transfections utilizing COX-2 promoter deletion constructs and COX-2 promoter constructs, in which specific enhancer elements were mutagenized, indicated that the effects of PMA and resveratrol were mediated via a cyclic AMP response element. Resveratrol inhibited PMA- mediated activation of protein kinase C. Overexpressing protein kinase C-α, ERK1, and c-Jun led to 4.7-, 5.1-, and 4-fold increases in COX-2 promoter activity, respectively. These effects also were inhibited by resveratrol. Resveratrol blocked PMA-dependent activation of AP-1-mediated gene expression. In addition to the above effects on gene expression, we found that resveratrol also directly inhibited the activity of COX-2. These data are likely to be important for understanding the anti-cancer and anti- inflammatory properties of resveratrol.
Keywords: human cell; promoter region; cells, cultured; enzyme inhibition; breast; transcription initiation; membrane proteins; transcription, genetic; carcinogenesis; enzyme inhibitors; eukaryota; cyclooxygenase 2; anti-inflammatory agents, non-steroidal; immunoblotting; epithelium cell; epithelial cells; gene control; protein kinase c; antiinflammatory activity; antioxidant activity; resveratrol; mutagenesis; breast cell; isoenzymes; phorbol ester; enzyme induction; northern blotting; tetradecanoylphorbol acetate; enhancer region; promoter regions (genetics); prostaglandin-endoperoxide synthases; stilbenes; humans; human; female; priority journal; article; vitaceae
Journal Title: Journal of Biological Chemistry
Volume: 273
Issue: 34
ISSN: 0021-9258
Publisher: American Society for Biochemistry and Molecular Biology  
Date Published: 1998-08-21
Start Page: 21875
End Page: 21882
Language: English
DOI: 10.1074/jbc.273.34.21875
PUBMED: 9705326
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors